Evaluation of real time PCR technique to diagnosis of human T-lymphotropic virus type i (HTLV-I) in patients in the Hematologia da Fundação Hemope Hospital, in Northeastern Brazil

Revista Brasileira de Hematologia e Hemoterapia

Volumn 30, Issue 5, 2008, Pages 384-389

  Arruda, Bruna C ^a,f   Lira, Rodrigo A ^b,f   Loureiro, Paula ^c,f   Brandão, Lucas ^d,f   Souza, Paulo ^e,f   Souza, Wayner V ^b,f   Gomes, Yara M ^b,f  

^a Fundacao Hemope   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Médica da Fundação Hemope

^d UFPE PE ^*

^e FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^f FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

HTLV I injections; Human T cell lymphotropic virus; Molecular diagnosis; Polymerase chain reaction

Indexed keywords

EID: 58049169825     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842008000500011     Document Type: Article

References (21)

1. a. Edição, p.103-110, Rio de Janeiro, 2001.
2. Catalan-Soares B, Carneiro-Proietti AB, Proietti FA; Interdisciplinary HTLV Research Group. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil. Cad Saude Publica. 2005;21(3):926-31.
3. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, et al. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000, 1990-2000. CMAJ. 2003;169 (8):767-73.
4. LaI RB, Heneine W, Rudolph DL, Present WB, Hofnienz D, Hartley TM, et al. Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals. J Clin Microbiol. 1991; 29 (10):2253-8.
5. Hadlock KG, Lipka JJ, Chow TP, Foung SK, Reyes GR. Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II. Blood. 1992; 79(10):2789-96.
6. Santos Tde J, Costa CM, Goubau P, Vandamme AM, Desmyter J, Van Doren S, et al. Western blot seroindetenninate individuals for human T-lymphotropic virus I/II (HTLV-I/II) in Fortaleza (Brazil): a serological and molecular diagnostic and epidemiological approach. Braz J Infect Dis. 2003;7(3);202-9.
7. Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R, Gessain A. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology. 2005;2:30.
8. Switzer WM, Hewlett I, Aaron L, Wolfe ND, Burke DS, Heneine W. Serologic testing for human T-lymphotropic virus-3 and -4. Transfusion. 2006;46(9):1647-8.
9. Mackay IM, Arden KE, Nitsche A. Real-time PCR in virology. Nucleic Acids Res. 2002;30(6):1292-305.
10. Lee TH, Chafers DM, Busch MP, Murphy EL. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. J Clin Virol. 2004;31(4):275-82.
11. Dehée A, Césaire R, Désiré N, Lézin A, Bourdonné O, Béra O, et al Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods. 2002;102(1-2):37-51.
12. De Bias I, Ortega C, Frankena K, Noordhuizen J, Thrusfield M. Programa de estatística: Win Episcope 2.0. Facilidad de Veterinaria, 2000. Zaragoza, Wageningen University, University of Edinburgh.
13. Ministério da Saúde. Secretaria em Vigilância da Saúde. Programa Nacional de DST Aids. Guia de manejo clínico de HTLV. Brasília, 2003.
14. Morimoto HK, Morimoto AA, Reiche EM, Ueda LT, Matsuo T, Reiche FV, et al. Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype. Rev Inst Med Trop Sao Paulo. 2007;49(4):225-30.
15. Gallego S, Mangano A, Gastaldello R, Sen L, Medeot S. Usefulness of a Nested-polymerase chain reaction for molecular diagnosis of human T-cell lymphotropic virus type I/II. Mem Inst Oswaldo Cruz. 2004;99(4):377-80.
16. Gunson RN, Collins TC, Carman WF. Practical experience of high throughput real time PCR in the routine diagnostic virology setting. J Clin Virol. 2006;35(4):355-67.
17. Watzinger F, Ebner K, Lion T. Detection and monitoring of virus infections by real-time PCR. Mol Aspects Med. 2006;27(2-3):254-98.
18. Tosswill JH, Taylor GP, Clewley JP, Weber JN. Quantification of proviral DNA load in human T-cell leukaemia virus type I infections. J Virol Methods. 1998;75(1):21-6.
19. Montanheiro PA, Oliveira AC, Posada-Vergara MP, Milagres AC, Tauil C, Marchiori PE, et al. Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Braz J Med Biol Res. 2005;38(11):1643-7.
20. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998; 4(6):586-93.
21. Osame M, Matsuzaki T, Nakagawa M, Nagai M, Usuku K, Higuchi I, et al. HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years. J Neurovirol. 2001;7(3):228-34.